Mylotarg 4.5Mg Injection
₹ 0.00₹ 0.00
Brand: Mylotarg
Generic: Gemtuzumab Ozogamicin
Manufacturer: Pfizer
Drug class: CD33-directed antibody-drug conjugate (ADC).
Description
Introduction to Mylotarg 4.5mg Injection
Mylotarg 4.5mg Injection is a prescription medicine used to treat certain types of acute myeloid leukemia (AML). It contains gemtuzumab ozogamicin, a targeted cancer medicine that works by helping destroy certain leukemia cells.
Mylotarg 4.5mg Injection is given through an intravenous (IV) infusion by a qualified healthcare professional. The dose and treatment schedule depend on the patient’s condition and the doctor’s treatment plan.
Like other cancer medicines, Mylotarg may cause side effects. Patients should use this medicine only under the supervision of their doctor and report any unusual or serious symptoms during treatment.




Reviews
There are no reviews yet.